AMICUS THERAPEUTICS INC — Form D

AMICUS THERAPEUTICS INC of CRANBURY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-13. The offering totals $199.9M, of which $199.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (76)

Showing 25 of 76 people.

NameRoleLocation
Bradley L CampbellDirectorCranbury, NJ
Robert D EssnerDirectorPhiladelphia, PA
Eiry L RobertsDirectorPhiladelphia, PA
David M ClarkExecutive OfficerPhiladelphia, PA
Samantha M ProutExecutive OfficerPhiladelphia, PA
Daphne L QuimiExecutive OfficerPhiladelphia, PA
David ClarkExecutive OfficerLafayette, CO
Bradley CampbellDirectorTampa, FL
Bradley CampbellExecutive OfficerTampa, FL
John F CrowleyDirectorPrinceton, NJ
John F CrowleyExecutive OfficerPrinceton, NJ
Eiry W Roberts, M.D.DirectorPrinceton, NJ
Ellen S RosenbergExecutive OfficerPrinceton, NJ
Craig A WheelerDirectorPrinceton, NJ
Michael A KellyDirectorPrinceton, NJ
Michael G RaabDirectorPrinceton, NJ
Simon HarfordExecutive OfficerPrinceton, NJ
Glenn P SblendorioDirectorPrinceton, NJ
Burke W WhitmanDirectorPrinceton, NJ
Lynn D BleilDirectorPrinceton, NJ
Jeffrey P Castelli, Ph.D.Executive OfficerPrinceton, NJ
John CrowleyDirectorAlameda, CA
John CrowleyExecutive OfficerAlameda, CA
Donald J Hayden, Jr.DirectorPhiladelphia, PA
David J LockhartExecutive OfficerMenlo Park, CA

Other filings by this issuer (6)

FiledFormOfferingSold
2023-10-16D$30.0M$30.0M
2016-07-19D$4.7M$4.7M
2013-12-03D$15.0M$15.0M
2013-12-03D$15.0M$15.0M
2012-07-30D$18.6M$18.6M
2010-11-05D$31.3M$31.3M

More